Agency Forms Undergoing Paperwork Reduction Act Review, 70163-70164 [2020-24473]
Download as PDF
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
infection immediately upon notifying
medical staff of symptom onset. These
results must be reported to CDC in
aggregate through the EDC form.
Shoreside COVID–19 Laboratory
Screening Testing of All Embarking
Crew
(1) On the day of crew members’
embarkation, cruise ship operators must
collect specimens for SARS-CoV–2
testing from all embarking land-based
crew. Cruise ship operators must
immediately transport the specimens to
a CLIA-certified laboratory for testing.
(2) This laboratory must use an RT–
PCR test that has been approved,
cleared, or authorized for emergency use
by FDA. Cruise ship operators must
report results in aggregate to CDC
through the EDC form. CDC must
approve the cruise ship operator’s
selection of a CLIA-certified laboratory.
(3) All embarking land-based crew
must be immediately quarantined
onboard for 14 days. Those who test
positive must be isolated until criteria
are met for discontinuation of isolation
according to the most current CDC
guidance. CDC may also oversee the
collection of specimens, or the
quarantine or isolation of embarking
crew, through remote means allowing
for visual observation.
khammond on DSKJM1Z7X2PROD with NOTICES
Continued Compliance With No Sail
Order (NSO) Response Plans
(1) Cruise ship operators must
continue to follow their cruise lines’
complete, accurate, and acknowledged
NSO response plans per the No Sail
Order and Suspension of Further
Embarkation; Notice of Modification
and Extension and Other Measures
Related to Operations published at 85
FR 21004 (April 15, 2020) (i.e., ‘‘No Sail
Order response plan’’), as modified and
extended July 16, 2020 (published at 85
FR 44085 (July 21, 2020)), and
September 30, 2020 (published at 85 FR
62732 (October 5, 2020)).
(2) Cruise ship operators must also
continue to follow CDC’s Interim
Guidance for Mitigation of COVID–19
Among Cruise Ship Crew and COVID–
19 Color-coding System for Cruise
Ships, which may be modified or
updated as needed. CDC will notify
cruise ship operators of any updates.
Ship-to-ship crew transfers and
embarkations may continue to impact
ships’ color-coding status. For
additional information about other
public health preventive measures, such
as social distancing, mask use, and
cabin occupancy, refer to CDC’s Interim
Guidance.
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
Effective Date and Signature
This Order is effective upon signature
and shall remain in effect until the
earliest of (1) the expiration of the
Secretary of Health and Human
Services’ declaration that COVID–19
constitutes a public health emergency;
(2) the CDC Director rescinds or
modifies the order based on specific
public health or other considerations; or
(3) November 1, 2021.
Authority: The authority for these orders
is Sections 361 and 365 of the Public Health
Service Act (42 U.S.C. 264, 268) and 42 CFR
70.2, 71.31(b), 71.32(b).
Dated: October 30, 2020.
Nina B. Witkofsky,
Acting Chief of Staff, Centers for Disease
Control and Prevention.
[FR Doc. 2020–24477 Filed 10–30–20; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–20PA]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘DOP CrossSite Program Implementation
Evaluation of Overdose Data to Action
Program’’ to the Office of Management
and Budget (OMB)for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on 06/15/
2020 to obtain comments from the
public and affected agencies. CDC did
not receive public comments related to
the previous notice. This notice serves
to allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencie’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
70163
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
DOP Cross-Site Program
Implementation Evaluation of Overdose
Data to Action Program—New—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Overdose Data to Action (OD2A)
program is a comprehensive, national
overdose prevention program developed
by CDC. The purpose of the OD2A
program is to support funded
jurisdictions in obtaining high quality,
complete, and timely data on opioid
prescribing and overdoses, and to use
those data to inform prevention and
response efforts. OD2A funds a total of
66 recipients (state and local health
departments) to implement surveillance
and prevention strategies, through a
three-year cooperative agreement.
This information collection review is
focused on the tools needed to evaluate
the unique OD2A program. This
information collection includes key
informant interviews (KII) and focus
groups (FG). The information collection
is unique and will be the first evaluation
of the OD2A program. There are no
other efforts that CDC knows of to
obtain program information required to
E:\FR\FM\04NON1.SGM
04NON1
70164
Federal Register / Vol. 85, No. 214 / Wednesday, November 4, 2020 / Notices
demonstrate impact and improve
implementation of OD2A. The purpose
of this information collection is to
assess the implementation and the
effectiveness of the OD2A program
activities and identify the conditions
under which these activities are most
effective, and for whom. The
implementation evaluation will identify
the barriers and facilitators associated
with deploying several prevention
activities targeting specific populations
within specific jurisdictions.
Data collected from this evaluation
will be used by the CDC to obtain valid
information regarding how recipients
operationalized and implemented their
chosen prevention activities, to assess
the impact of OD2A and different
components of OD2A on the trajectory
of the opioid epidemic, and through the
provision of these data back to the
recipients, to improve the
implementation and impact of further
OD2A prevention activities. There are
no costs to the respondents other than
their time. The total estimated
annualized burden hours are 574.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Jurisdictions implementing OD2A program ....
Key Informant Interview Guides .....................
Focus Group Guides ......................................
Permission to be Recorded ...........................
Interview Recruitment Email ..........................
Focus Group Recruitment Email ....................
Interview Recruitment Reminder Email .........
Focus Group Recruitment Reminder Email ...
Post-information Collection Follow up Email
Program Manager Focus Group Recruitment
Request Email.
Program Manager Interview Recruitment Request Email.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–24473 Filed 11–3–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–20OG]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Assessments
of adults’ professional experiences for
improving programs to decrease sexual
risk and related behaviors and adverse
health outcomes among youth,’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on June 2, 2020 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
VerDate Sep<11>2014
18:16 Nov 03, 2020
Jkt 253001
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(hours )
181
165
346
181
165
181
165
346
165
1
1
1
1
1
1
1
1
1
1
1.5
5/60
5/60
5/60
5/60
5/60
5/60
5/60
181
1
5/60
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Assessments of adults’ professional
experiences for improving programs to
decrease sexual risk and related
behaviors and adverse health outcomes
among youth—New—Division of
Adolescent and School Health, National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) requests approval for
a new generic information collection
package that supports collection of
quantitative and qualitative information
from adults who help implement
programs and services designed to
prevent HIV, other sexually transmitted
diseases (STDs), and pregnancy or
influence related risk and protective
factors; data will be collected for needs
E:\FR\FM\04NON1.SGM
04NON1
Agencies
[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Pages 70163-70164]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24473]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-20PA]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``DOP Cross-Site Program Implementation
Evaluation of Overdose Data to Action Program'' to the Office of
Management and Budget (OMB)for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on 06/15/2020 to obtain comments from the
public and affected agencies. CDC did not receive public comments
related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencie's estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
DOP Cross-Site Program Implementation Evaluation of Overdose Data
to Action Program--New--National Center for Injury Prevention and
Control (NCIPC), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Overdose Data to Action (OD2A) program is a comprehensive,
national overdose prevention program developed by CDC. The purpose of
the OD2A program is to support funded jurisdictions in obtaining high
quality, complete, and timely data on opioid prescribing and overdoses,
and to use those data to inform prevention and response efforts. OD2A
funds a total of 66 recipients (state and local health departments) to
implement surveillance and prevention strategies, through a three-year
cooperative agreement.
This information collection review is focused on the tools needed
to evaluate the unique OD2A program. This information collection
includes key informant interviews (KII) and focus groups (FG). The
information collection is unique and will be the first evaluation of
the OD2A program. There are no other efforts that CDC knows of to
obtain program information required to
[[Page 70164]]
demonstrate impact and improve implementation of OD2A. The purpose of
this information collection is to assess the implementation and the
effectiveness of the OD2A program activities and identify the
conditions under which these activities are most effective, and for
whom. The implementation evaluation will identify the barriers and
facilitators associated with deploying several prevention activities
targeting specific populations within specific jurisdictions.
Data collected from this evaluation will be used by the CDC to
obtain valid information regarding how recipients operationalized and
implemented their chosen prevention activities, to assess the impact of
OD2A and different components of OD2A on the trajectory of the opioid
epidemic, and through the provision of these data back to the
recipients, to improve the implementation and impact of further OD2A
prevention activities. There are no costs to the respondents other than
their time. The total estimated annualized burden hours are 574.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours )
----------------------------------------------------------------------------------------------------------------
Jurisdictions implementing OD2A Key Informant Interview 181 1 1
program. Guides.
Focus Group Guides...... 165 1 1.5
Permission to be 346 1 5/60
Recorded.
Interview Recruitment 181 1 5/60
Email.
Focus Group Recruitment 165 1 5/60
Email.
Interview Recruitment 181 1 5/60
Reminder Email.
Focus Group Recruitment 165 1 5/60
Reminder Email.
Post-information 346 1 5/60
Collection Follow up
Email.
Program Manager Focus 165 1 5/60
Group Recruitment
Request Email.
Program Manager 181 1 5/60
Interview Recruitment
Request Email.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-24473 Filed 11-3-20; 8:45 am]
BILLING CODE 4163-18-P